Qube Research & Technologies (QRT)’s HashiCorp, Inc. Class A Common Stock HCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,182,988
Closed -$74.7M 3979
2024
Q4
$74.7M Buy
2,182,988
+252,860
+13% +$8.57M 0.1% 260
2024
Q3
$65.4M Buy
1,930,128
+1,460,596
+311% +$49.3M 0.1% 265
2024
Q2
$15.8M Buy
+469,532
New +$14.6M 0.03% 711
2023
Q3
Sell
-33,664
Closed -$881K 4375
2023
Q2
$881K Sell
33,664
-74,606
-69% -$2.19M ﹤0.01% 1353
2023
Q1
$3.17M Sell
108,270
-66,444
-38% -$1.98M 0.01% 811
2022
Q4
$4.78M Buy
174,714
+139,656
+398% +$3.95M 0.03% 683
2022
Q3
$1.13M Buy
35,058
+20,785
+146% +$717K 0.01% 1159
2022
Q2
$420K Buy
+14,273
New +$576K ﹤0.01% 1478
2022
Q1
Sell
-2,400
Closed -$218K 3127
2021
Q4
$218K Buy
+2,400
New +$209K ﹤0.01% 1935

Other funds holding HCP

Qube Research & Technologies (QRT)'s HCP Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of HashiCorp, Inc. Class A Common Stock (HCP) in Q1 2025, closing a stake of 2,182,988 shares — an estimated $74.7M sold.

Qube Research & Technologies (QRT) first reported a position in HCP in Q4 2021 and held it in 9 quarters. The position peaked at $74.7M in Q4 2024. 4 funds tracked by Wall St. Rank hold HCP as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining HashiCorp, Inc. Class A Common Stock position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,182,988 HashiCorp, Inc. Class A Common Stock shares in Q1 2025, an estimated $74.7M.
  • Qube Research & Technologies (QRT) first reported a position in HashiCorp, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s HashiCorp, Inc. Class A Common Stock position peaked at $74.7M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held HashiCorp, Inc. Class A Common Stock as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.